Literature DB >> 17044842

Menstrual migraine: pathophysiology, diagnosis, and impact.

Elizabeth W Loder1.   

Abstract

The incidence of migraine varies over the course of the menstrual cycle. In the general population, approximately 60% of women with migraine report an increased frequency of headache during menses. The estrogen withdrawal that occurs just prior to the onset of menses and that leads to loss of serotonergic tone is thought to be the trigger for headaches that arise at this time of the menstrual cycle. The ability of triptans, specific serotonin receptor agonists, to prevent menstrual migraine is consistent with this hypothesis. Moreover, compared with headaches that occur during other times in the cycle, menstrual migraines are more severe in most women and may be of longer duration, as well as more resistant to treatment in a subset of women.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17044842     DOI: 10.1111/j.1526-4610.2006.00555.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  5 in total

Review 1.  Hormonal contraception and migraine: clinical considerations.

Authors:  Stephanie S Faubion; Petra M Casey; Lynne T Shuster
Journal:  Curr Pain Headache Rep       Date:  2012-10

2.  Altered trigeminal system excitability in menstrual migraine patients.

Authors:  Ayhan Varlibas; A Kemal Erdemoglu
Journal:  J Headache Pain       Date:  2009-06-04       Impact factor: 7.277

Review 3.  Perimenstrual migraines: are they different from migraines in general?

Authors:  Stewart J Tepper
Journal:  Curr Pain Headache Rep       Date:  2008-12

Review 4.  Triggers, Protectors, and Predictors in Episodic Migraine.

Authors:  Michael J Marmura
Journal:  Curr Pain Headache Rep       Date:  2018-10-05

Review 5.  New Insights on Metabolic and Genetic Basis of Migraine: Novel Impact on Management and Therapeutical Approach.

Authors:  Irene Simonetta; Renata Riolo; Federica Todaro; Antonino Tuttolomondo
Journal:  Int J Mol Sci       Date:  2022-03-11       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.